These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27401840)

  • 21. Prognostic factors of 87 ovarian yolk sac tumor (OYST) patients and molecular characteristics of persistent and recurrent OYST.
    Liang S; Ge H; Zhou S; Tang J; Gu Y; Wu X; Li J
    Gynecol Oncol; 2024 Aug; 187():64-73. PubMed ID: 38733954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
    Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
    J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium.
    O'Neill AF; Xia C; Krailo MD; Shaikh F; Pashankar FD; Billmire DF; Olson TA; Amatruda JF; Villaluna D; Huang L; Malogolowkin M; Rodriguez-Galindo C; Frazier AL
    Cancer; 2019 Oct; 125(20):3649-3656. PubMed ID: 31355926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
    Wang YK; Shen L; Jiao X; Zhang XT
    World J Gastroenterol; 2018 Jan; 24(2):266-273. PubMed ID: 29375212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study on the microheterogeneity of alpha-fetoproteins produced by yolk sac and germ cell tumors.
    Yamamoto R; Ohkouchi T; Wakui Y; Minobe S; Watari H; Shimizu K; Satomura S; Sakuragi N
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):876-82. PubMed ID: 12911452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
    Cushing B; Giller R; Ablin A; Cohen L; Cullen J; Hawkins E; Heifetz SA; Krailo M; Lauer SJ; Marina N; Rao PV; Rescorla F; Vinocur CD; Weetman RM; Castleberry RP
    Am J Obstet Gynecol; 1999 Aug; 181(2):353-8. PubMed ID: 10454682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of serum α-fetoprotein in ovarian yolk sac tumors: A systematic review and meta-analysis.
    Guo YL; Zhang YL; Zhu JQ
    Mol Clin Oncol; 2015 Jan; 3(1):125-132. PubMed ID: 25469282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma.
    Wang Y; Zhou F; Qian Z; Qing J; Zhao M; Huang L
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S198-200. PubMed ID: 25518772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases.
    Chen J; Wang J; Cao D; Yang J; Shen K; Huang H; Shi X
    Arch Gynecol Obstet; 2021 Oct; 304(4):1043-1053. PubMed ID: 33751209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
    Fresneau B; Orbach D; Faure-Conter C; Sudour-Bonnange H; Vérité C; Gandemer V; Pasquet M; Fasola S; Rome A; Raimbault S; Martelli H; Frappaz D; Le Teuff G; Patte C
    Eur J Cancer; 2018 May; 95():11-19. PubMed ID: 29604495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical analysis of stage I pediatric testicular yolk sac tumors: a report of ten cases].
    Ye YL; Qin ZK; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Chen ZF
    Ai Zheng; 2008 Nov; 27(11):1226-8. PubMed ID: 19000459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conservative treatment of big yolk sac tumour of the ovary in young girl.
    Beurdeley M; Gauthier T; Piguet C; Fourcade L
    J Visc Surg; 2010 Aug; 147(4):e265-7. PubMed ID: 20920902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
    You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
    Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucinous carcinoid as an unusual manifestation of endodermal differentiation in ovarian yolk sac tumors.
    Nogales FF; Buriticá C; Regauer S; González T
    Am J Surg Pathol; 2005 Sep; 29(9):1247-51. PubMed ID: 16096416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
    Wang R; Li J; Xu D; Li R; Gong P
    Medicine (Baltimore); 2020 Nov; 99(47):e23326. PubMed ID: 33217870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.
    Abe A; Furumoto H; Yoshida K; Nishimura M; Irahara M; Kudo E; Sano T
    Int J Gynecol Cancer; 2008; 18(1):168-72. PubMed ID: 17466041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy.
    Murphy BA; Motzer RJ; Mazumdar M; Vlamis V; Nisselbaum J; Bajorin D; Bosl GJ
    Cancer; 1994 May; 73(10):2520-6. PubMed ID: 7513603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
    Rebischung C; Pautier P; Morice P; Lhomme C; Duvillard P
    Gynecol Oncol; 2000 Apr; 77(1):203-5. PubMed ID: 10739713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.